Reprogramming Stars #22: Cellular Reprogramming as a Route for Decoding Neurodegenerative Disorders—An Interview with Dr. Janelle Drouin-Ouellet

Abstract

Get full access to this article

View all access options for this article.

References

Armanville

, Tocco

, Haj Mohamad

, et al. Chemically induced senescence prompts functional changes in human microglia‐like cells. J Immunol Res, 2025; 2025(1):3214633.

Drouin-Ouellet

, Legault

, Nilsson

, et al. Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson’s disease. Stem Cell Reports, 2022; 17(10):2203–2219.

Merlevede

, Legault

, Drugge

, et al. A quantitative model of cellular decision making in direct neuronal reprogramming. Sci Rep, 2021; 11(1):1514.

Parmar

, Torper

, Drouin‐Ouellet

. Cell‐based therapy for Parkinson’s disease: A journey through decades toward the light side of the Force. Eur J Neurosci, 2019; 49(4):463–471.

Pircs

, Drouin-Ouellet

, Horváth

, et al. Distinct subcellular autophagy impairments in induced neurons from patients with Huntington’s disease. Brain, 2022; 145(9):3035–3057.